STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Clinical trials for STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo attack on HPV-Linked throat cancer
Disease control OngoingThis study is testing whether combining two immunotherapy drugs (ipilimumab and nivolumab) with a targeted course of radiation is safe and effective for treating advanced throat cancer caused by HPV. The goal is to help the body's immune system better recognize and attack the can…
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 04:05 UTC
-
New drug duo aims to shrink tough head and neck cancers
Disease control OngoingThis study is testing whether a combination of two drugs, pembrolizumab and cabozantinib, can help control advanced head and neck cancer that has come back or spread. The trial will involve about 36 patients whose cancer cannot be removed by surgery. Researchers want to see if th…
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Major trial tests drug combo in fight against advanced head and neck cancer
Disease control OngoingThis large, late-stage trial is testing whether adding the drug bevacizumab to standard chemotherapy helps patients with advanced head and neck cancer that has returned or spread. The study enrolled 403 participants to see if the combination helps people live longer or slows canc…
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Head-to-Head cancer radiation trial: protons vs. photons
Disease control OngoingThis study aims to find out if a newer type of radiation called proton beam therapy is better than standard photon therapy for treating throat cancer. It will compare how well each treatment controls the cancer and, importantly, which one causes fewer severe side effects. About 4…
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC